SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse modelJingxin Qiao, Shengyong Yang, Yifei Wang et al.|Science|2021Cited by 449
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including OmicronBaoxue Quan, Shengyong Yang, Huiping Shuai et al.|Nature Microbiology|2022Cited by 101
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variantsChong Huang, Shengyong Yang, Huiping Shuai et al.|Signal Transduction and Targeted Therapy|2023Cited by 82